Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

VolitionRX Ltd (NYSE MKT LLC:VNRX)

3.70
Delayed Data
As of Jul 31
 +0.10 / +2.78%
Today’s Change
1.45
Today|||52-Week Range
9.28
-5.13%
Year-to-Date
SECTOR
Health Services
INDUSTRY
Medical/Nursing Services
MARKET CAP
$66.4M

Company Description

VolitionRX Ltd. operates clinical-stage life sciences company, which focuses on developing blood-based diagnostic tests that meet the need for accurate, fast, inexpensive and scalable tests for detecting and diagnosing cancer and other diseases. The company was founded on August 5, 2010 and is headquartered in Singapore.

Contact Information

VolitionRX Ltd.
1 Scotts Road
Singapore Central Singapore 228208
P:
Investor Relations:
(646) 650-1351

Employees

Shareholders

Other institutional8.19%
Individual stakeholders24.51%
Mutual fund holders0.01%

Top Executives

Cameron John ReynoldsPresident, Chief Executive Officer & Director
Mike O'ConnellChief Financial Officer & Treasurer
Jason Bradley TerrellChief Medical Officer & Head-US Operations
Jacob Vincent MicallefChief Scientific Officer
Thomas BygottDirector-Sales & Marketing